1. Additional bevacizumab in EGFR-mutant lung adenocarcinoma patients who had oligo-progression after the failure of EGFR-TKI: A single-institute retrospective study. (2020) Authors: Kashiwabara, Kosuke; Fujii, Shinji; Tsumura, Shinsuke; Sakamoto, Kazuhiko; Semba, Hiroshi Journal: Cancer treatment and research communications Issue: Number 22(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer. (April 2012) Authors: Hamada, Akinobu; Sasaki, Ji-ichiro; Saeki, Sho; Iwamoto, Norihiro; Inaba, Megumi; Ushijima, Sunao; Urata, Maki; Kishi, Hiroto; Fujii, Shinji; Semba, Hiroshi; Kashiwabara, Kosuke; Tsubata, Yukari; Kai, Yuki; Isobe, Takeshi; Kohrogi, Hirotsugu; Saito, Hideyuki Journal: Pharmacogenomics Issue: Volume 13:Number 5(2012) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer. (April 2012) Authors: Hamada, Akinobu; Sasaki, Ji-ichiro; Saeki, Sho; Iwamoto, Norihiro; Inaba, Megumi; Ushijima, Sunao; Urata, Maki; Kishi, Hiroto; Fujii, Shinji; Semba, Hiroshi; Kashiwabara, Kosuke; Tsubata, Yukari; Kai, Yuki; Isobe, Takeshi; Kohrogi, Hirotsugu; Saito, Hideyuki Journal: Pharmacogenomics Issue: Volume 13:Number 5(2012) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer. (April 2012) Authors: Hamada, Akinobu; Sasaki, Ji-ichiro; Saeki, Sho; Iwamoto, Norihiro; Inaba, Megumi; Ushijima, Sunao; Urata, Maki; Kishi, Hiroto; Fujii, Shinji; Semba, Hiroshi; Kashiwabara, Kosuke; Tsubata, Yukari; Kai, Yuki; Isobe, Takeshi; Kohrogi, Hirotsugu; Saito, Hideyuki Journal: Pharmacogenomics Issue: Volume 13:Number 5(2012) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Outcomes of gefitinib therapy for disease recurrence in medically inoperable stage I lung adenocarcinoma patients with active EGFR mutations receiving stereotactic body radiotherapy: a single-institute retrospective study. Issue 1 (March 2019) Authors: Kashiwabara, Kosuke; Semba, Hiroshi; Fujii, Shinji; Tsumura, Shinsuke Journal: International journal of surgery Issue: Volume 4:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A). Issue 1 (24th November 2016) Authors: Fukuda, Minoru; Shimada, Midori; Kitazaki, Takeshi; Nagashima, Seiji; Hashiguchi, Kohji; Ebi, Noriyuki; Takayama, Koichi; Nakanishi, Yoichi; Semba, Hiroshi; Harada, Taishi; Seto, Takashi; Okamoto, Isamu; Ichinose, Yukito; Sugio, Kenji Journal: Thoracic cancer Issue: Volume 8:Issue 1(2017) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase II study of vinorelbine plus carboplatin with concurrent radiotherapy in elderly patients with non-small cell lung cancer. (7th December 2019) Authors: Yamaguchi, Masafumi; Hirata, Hideki; Ebi, Noriyuki; Araki, Jun; Seto, Takashi; Maruyama, Riichiroh; Akamine, Shinji; Inoue, Yuichi; Semba, Hiroshi; Sasaki, Jiichiro; Okamoto, Tatsuro Journal: Japanese journal of clinical oncology Issue: Volume 50:Number 3(2020) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase II trial of weekly nab-paclitaxel for previously treated advanced non–small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301. (September 2016) Authors: Sakata, Shinya; Saeki, Sho; Okamoto, Isamu; Otsubo, Kohei; Komiya, Kazutoshi; Morinaga, Ryotaro; Yoneshima, Yasuto; Koga, Yuichiro; Enokizu, Aimi; Kishi, Hiroto; Hirosako, Susumu; Yamaguchi, Emi; Aragane, Naoko; Fujii, Shinji; Harada, Taishi; Iwama, Eiji; Semba, Hiroshi; Nakanishi, Yoichi; Kohrog... Journal: Lung cancer Issue: Volume 99(2016) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Preoperative Percutaneous Transthoracic Needle Biopsy Increased the Risk of Pleural Recurrence in Pathological Stage I Lung Cancer Patients With Sub-pleural Pure Solid Nodules. (13th September 2016) Authors: Kashiwabara, Kosuke; Semba, Hiroshi; Fujii, Shinji; Tsumura, Shinsuke Journal: Cancer investigation Issue: Volume 34:Number 8(2016) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B). Issue 4 (11th May 2016) Authors: Fukuda, Minoru; Suetsugu, Takayuki; Shimada, Midori; Kitazaki, Takeshi; Hashiguchi, Kohji; Kishimoto, Junji; Harada, Taishi; Seto, Takashi; Ebi, Noriyuki; Takayama, Koichi; Sugio, Kenji; Semba, Hiroshi; Nakanishi, Yoichi; Ichinose, Yukito Journal: Thoracic cancer Issue: Volume 7:Issue 4(2016) Page Start: 467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗